{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:05:07Z","timestamp":1788743107607,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2017,10,29]],"date-time":"2017-10-29T00:00:00Z","timestamp":1509235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570535"],"award-info":[{"award-number":["81570535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["134119a2400"],"award-info":[{"award-number":["134119a2400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["12XD1403600"],"award-info":[{"award-number":["12XD1403600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Transient elastography (<jats:styled-content style=\"fixed-case\">TE<\/jats:styled-content>) is accurate in staging fibrosis noninvasively. However, a reliable serum biomarker with comparable accuracy is also important, especially when <jats:styled-content style=\"fixed-case\">TE<\/jats:styled-content> is unreliable\/unavailable. Therefore, we aimed to evaluate the diagnostic performance of serum Golgi protein 73 (<jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73) for significant fibrosis in patients with chronic <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection. A total of 801 patients with chronic liver disease (CLD; 492 chronic <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection and 309 non\u2010<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> liver disease) with liver biopsy performance were enrolled. Healthy controls (n\u00a0=\u00a0180) and hepatocellular carcinoma (<jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>) patients (n\u00a0=\u00a085) were included for comparisons. Liver biopsy was used as the reference method for fibrosis staging. Serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 level was measured in duplicate in double\u2010blind fashion. Serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 was highest in <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content> but also significantly higher in chronic hepatitis B than in healthy controls. The elevation of serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 in non\u2010<jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content> patients was significantly associated with the presence of significant fibrosis independently of <jats:styled-content style=\"fixed-case\">ALT<\/jats:styled-content> level, liver stiffness (LS) value, inflammation grade and other confounding factors. The diagnostic performance of serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 was accurate in antiviral\u2010na\u00efve <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> patients (area under the receiver operating curve [<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>], 0.76 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.72\u20100.81) but not in patients with ongoing antiviral treatment (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>, 0.60). The utility of serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 was also confirmed in non\u2010<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> CLD (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>, 0.80 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.75\u20100.85). Serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 was comparable to LS (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>, 0.78 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.73\u20100.82) and significantly better than AST to platelet ratio index (<jats:styled-content style=\"fixed-case\">APRI<\/jats:styled-content>) (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>, 0.67 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.62\u20100.72) and <jats:styled-content style=\"fixed-case\">FIB<\/jats:styled-content>\u20104 (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>, 0.68 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.63\u20100.73). In conclusion, serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 is an accurate serum marker for significant fibrosis in chronic <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection, with higher accuracy than <jats:styled-content style=\"fixed-case\">APRI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">FIB<\/jats:styled-content>\u20104. Serum <jats:styled-content style=\"fixed-case\">GP<\/jats:styled-content>73 is potentially a complementary tool for <jats:styled-content style=\"fixed-case\">TE<\/jats:styled-content> when evaluating the necessity of antiviral treatment, particularly in patients without definite antiviral indication.<\/jats:p>","DOI":"10.1111\/jvh.12786","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T02:50:13Z","timestamp":1509331813000},"page":"57-65","source":"Crossref","is-referenced-by-count":34,"title":["Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic <scp>HBV<\/scp> infection"],"prefix":"10.1111","volume":"24","author":[{"given":"Z.","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology The Affiliated Infectious Diseases Hospital of Soochow University  Suzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease The Third Hospital of Changzhou  Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease The Third Hospital of Changzhou  Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatology The Affiliated Infectious Diseases Hospital of Soochow University  Suzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bao","sequence":"additional","affiliation":[{"name":"Discipline of Pathology School of Medical Sciences and Bosch Institute University of Sydney  Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30579-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61412-X"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27406"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.020"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60121-5"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28156"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.08.009"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23425"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.214916"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22843"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22994"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.08.010"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053862"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.3114"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000659"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14954"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32525"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30572.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.40410.x"},{"key":"e_1_2_8_25_1","unstructured":"World Health Organization (WHO).Guidelines for the prevention care and treatment of persons with chronic hepatitis b infection.http:\/\/apps.who.int\/iris\/bitstream\/10665\/154590\/1\/9789241549059_eng.pdf?ua=1&ua=1. Accessed July 1 2017."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.07.037"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90084-O"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25993"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88881"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9695-0"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9720-y"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.012"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309260"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13536"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440706"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12786","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T11:36:12Z","timestamp":1694604972000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,29]]},"references-count":37,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/jvh.12786"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12786","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,29]]}}}